Selected research
Industry Research
Anti-allergic Drugs Industry Research Report 2026
Market perspective
Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.
Report Scope
This report quantifies the global Anti-allergic Drugs market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
Read the full market overview
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Anti-allergic Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-allergic Drugs Market by Company
Sanofi
Johnson And Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
Anti-allergic Drugs Segment by Type
Oral Drugs
Non-Oral Drugs
Anti-allergic Drugs Segment by Sales Channel
Online
Offline
Anti-allergic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-allergic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-allergic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-allergic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anti-allergic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Drugs
- Non-Oral Drugs
Applications
- Online
- Offline
Companies covered
- Sanofi
- Johnson And Johnson
- Merck
- Teva
- GlaxoSmithKline
- Bayer
- Sun Pharma
- UCB Pharma
- Yangtze River Pharmaceutical Group
- Hainan Poly Pharm
- Chongqing Huapont Pharmaceutical
- Dawnrays
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Anti-allergic Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oral Drugs
- 2.2.3 Non-Oral Drugs
- 2.3 Anti-allergic Drugs by Sales Channel
- 2.3.1 Market Value Comparison by Sales Channel (2021 VS 2025 VS 2032)
- 2.3.2 Online
- 2.3.3 Offline
- 2.4 Assumptions and Limitations
3 Anti-allergic Drugs Breakdown Data by Type
- 3.1 Global Anti-allergic Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2027-2032)
4 Anti-allergic Drugs Breakdown Data by Sales Channel
- 4.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2021-2026)
- 4.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2027-2032)
5 Global Growth Trends
- 5.1 Global Anti-allergic Drugs Market Perspective (2021-2032)
- 5.2 Global Anti-allergic Drugs Growth Trends by Region
- 5.2.1 Global Anti-allergic Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Anti-allergic Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Anti-allergic Drugs Market Dynamics
- 5.3.1 Anti-allergic Drugs Industry Trends
- 5.3.2 Anti-allergic Drugs Market Drivers
- 5.3.3 Anti-allergic Drugs Market Challenges
- 5.3.4 Anti-allergic Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Anti-allergic Drugs Players by Revenue
- 6.1.1 Global Top Anti-allergic Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Anti-allergic Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Anti-allergic Drugs Head Office and Area Served
- 6.4 Global Anti-allergic Drugs Players, Product Type & Application
- 6.5 Global Anti-allergic Drugs Manufacturers Established Date
- 6.6 Global Anti-allergic Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Anti-allergic Drugs Market Size (2021-2032)
- 7.2 North America Anti-allergic Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Anti-allergic Drugs Market Size by Country (2021-2026)
- 7.4 North America Anti-allergic Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Anti-allergic Drugs Market Size (2021-2032)
- 8.2 Europe Anti-allergic Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Anti-allergic Drugs Market Size by Country (2021-2026)
- 8.4 Europe Anti-allergic Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-allergic Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Anti-allergic Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Anti-allergic Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Anti-allergic Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Anti-allergic Drugs Market Size (2021-2032)
- 10.2 South America Anti-allergic Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Anti-allergic Drugs Market Size by Country (2021-2026)
- 10.4 South America Anti-allergic Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-allergic Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Anti-allergic Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Anti-allergic Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sanofi
- 12.1.1 Sanofi Company Information
- 12.1.2 Sanofi Business Overview
- 12.1.3 Sanofi Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.1.4 Sanofi Anti-allergic Drugs Product Portfolio
- 12.1.5 Sanofi Recent Developments
- 12.2 Johnson And Johnson
- 12.2.1 Johnson And Johnson Company Information
- 12.2.2 Johnson And Johnson Business Overview
- 12.2.3 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.2.4 Johnson And Johnson Anti-allergic Drugs Product Portfolio
- 12.2.5 Johnson And Johnson Recent Developments
- 12.3 Merck
- 12.3.1 Merck Company Information
- 12.3.2 Merck Business Overview
- 12.3.3 Merck Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.3.4 Merck Anti-allergic Drugs Product Portfolio
- 12.3.5 Merck Recent Developments
- 12.4 Teva
- 12.4.1 Teva Company Information
- 12.4.2 Teva Business Overview
- 12.4.3 Teva Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.4.4 Teva Anti-allergic Drugs Product Portfolio
- 12.4.5 Teva Recent Developments
- 12.5 GlaxoSmithKline
- 12.5.1 GlaxoSmithKline Company Information
- 12.5.2 GlaxoSmithKline Business Overview
- 12.5.3 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.5.4 GlaxoSmithKline Anti-allergic Drugs Product Portfolio
- 12.5.5 GlaxoSmithKline Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.6.4 Bayer Anti-allergic Drugs Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 Sun Pharma
- 12.7.1 Sun Pharma Company Information
- 12.7.2 Sun Pharma Business Overview
- 12.7.3 Sun Pharma Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.7.4 Sun Pharma Anti-allergic Drugs Product Portfolio
- 12.7.5 Sun Pharma Recent Developments
- 12.8 UCB Pharma
- 12.8.1 UCB Pharma Company Information
- 12.8.2 UCB Pharma Business Overview
- 12.8.3 UCB Pharma Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.8.4 UCB Pharma Anti-allergic Drugs Product Portfolio
- 12.8.5 UCB Pharma Recent Developments
- 12.9 Yangtze River Pharmaceutical Group
- 12.9.1 Yangtze River Pharmaceutical Group Company Information
- 12.9.2 Yangtze River Pharmaceutical Group Business Overview
- 12.9.3 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.9.4 Yangtze River Pharmaceutical Group Anti-allergic Drugs Product Portfolio
- 12.9.5 Yangtze River Pharmaceutical Group Recent Developments
- 12.10 Hainan Poly Pharm
- 12.10.1 Hainan Poly Pharm Company Information
- 12.10.2 Hainan Poly Pharm Business Overview
- 12.10.3 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.10.4 Hainan Poly Pharm Anti-allergic Drugs Product Portfolio
- 12.10.5 Hainan Poly Pharm Recent Developments
- 12.11 Chongqing Huapont Pharmaceutical
- 12.11.1 Chongqing Huapont Pharmaceutical Company Information
- 12.11.2 Chongqing Huapont Pharmaceutical Business Overview
- 12.11.3 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.11.4 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product Portfolio
- 12.11.5 Chongqing Huapont Pharmaceutical Recent Developments
- 12.12 Dawnrays
- 12.12.1 Dawnrays Company Information
- 12.12.2 Dawnrays Business Overview
- 12.12.3 Dawnrays Revenue in Anti-allergic Drugs Business (2021-2026)
- 12.12.4 Dawnrays Anti-allergic Drugs Product Portfolio
- 12.12.5 Dawnrays Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst